BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 31695992)

  • 1. Biometals as Potential Predictors of the Neurodegenerative Decline in Alzheimer's Disease.
    Lavado LK; Zhang MH; Patel K; Khan S; Patel UK
    Cureus; 2019 Sep; 11(9):e5573. PubMed ID: 31695992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer's disease: Limitations, and current and future perspectives.
    Fasae KD; Abolaji AO; Faloye TR; Odunsi AY; Oyetayo BO; Enya JI; Rotimi JA; Akinyemi RO; Whitworth AJ; Aschner M
    J Trace Elem Med Biol; 2021 Sep; 67():126779. PubMed ID: 34034029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biometal Dyshomeostasis and Toxic Metal Accumulations in the Development of Alzheimer's Disease.
    Li Y; Jiao Q; Xu H; Du X; Shi L; Jia F; Jiang H
    Front Mol Neurosci; 2017; 10():339. PubMed ID: 29114205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Mechanisms of Metal Toxicity in the Pathogenesis of Alzheimer's Disease.
    Kabir MT; Uddin MS; Zaman S; Begum Y; Ashraf GM; Bin-Jumah MN; Bungau SG; Mousa SA; Abdel-Daim MM
    Mol Neurobiol; 2021 Jan; 58(1):1-20. PubMed ID: 32889653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metals and cholesterol: two sides of the same coin in Alzheimer's disease pathology.
    Wong BX; Hung YH; Bush AI; Duce JA
    Front Aging Neurosci; 2014; 6():91. PubMed ID: 24860500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic treatment of Alzheimer's disease using metal complexing agents.
    Price KA; Crouch PJ; White AR
    Recent Pat CNS Drug Discov; 2007 Nov; 2(3):180-7. PubMed ID: 18221229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.
    Wang WT; Tailor BA; Cohen DS; Huang X
    EC Pharmacol Toxicol; 2019 Jul; 7(7):547-558. PubMed ID: 31565701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary Data on the Interaction between Some Biometals and Oxidative Stress Status in Mild Cognitive Impairment and Alzheimer's Disease Patients.
    Balmuș IM; Strungaru SA; Ciobica A; Nicoara MN; Dobrin R; Plavan G; Ștefănescu C
    Oxid Med Cell Longev; 2017; 2017():7156928. PubMed ID: 28811866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in Multi-Functional Ligands and the Need for Metal-Related Pharmacology for the Management of Alzheimer Disease.
    Sharma A; Pachauri V; Flora SJS
    Front Pharmacol; 2018; 9():1247. PubMed ID: 30498443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease, metal ions and metal homeostatic therapy.
    Zatta P; Drago D; Bolognin S; Sensi SL
    Trends Pharmacol Sci; 2009 Jul; 30(7):346-55. PubMed ID: 19540003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metal ions influx is a double edged sword for the pathogenesis of Alzheimer's disease.
    Wang P; Wang ZY
    Ageing Res Rev; 2017 May; 35():265-290. PubMed ID: 27829171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of metals in Alzheimer's disease.
    Das N; Raymick J; Sarkar S
    Metab Brain Dis; 2021 Oct; 36(7):1627-1639. PubMed ID: 34313926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metal dyshomeostasis and oxidative stress in Alzheimer's disease.
    Greenough MA; Camakaris J; Bush AI
    Neurochem Int; 2013 Apr; 62(5):540-55. PubMed ID: 22982299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metal Ions in Alzheimer's Disease: A Key Role or Not?
    Liu Y; Nguyen M; Robert A; Meunier B
    Acc Chem Res; 2019 Jul; 52(7):2026-2035. PubMed ID: 31274278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Cerebral Metal Ion Imbalance in the Brain of Aging
    Braidy N; Poljak A; Marjo C; Rutlidge H; Rich A; Jugder BE; Jayasena T; Inestrosa NC; Sachdev PS
    Front Aging Neurosci; 2017; 9():66. PubMed ID: 28405187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of metals and Apolipoprotein E in Alzheimer's disease.
    Xu H; Finkelstein DI; Adlard PA
    Front Aging Neurosci; 2014; 6():121. PubMed ID: 24971061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of oxidative stress and other pathologies in Alzheimer's disease.
    Simunkova M; Alwasel SH; Alhazza IM; Jomova K; Kollar V; Rusko M; Valko M
    Arch Toxicol; 2019 Sep; 93(9):2491-2513. PubMed ID: 31440798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain biometals and Alzheimer's disease - boon or bane?
    Prakash A; Dhaliwal GK; Kumar P; Majeed AB
    Int J Neurosci; 2017 Feb; 127(2):99-108. PubMed ID: 27044501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurobiological pathways to Alzheimer's disease: Amyloid-beta, TAU protein or both?
    de Paula VJR; Guimarães FM; Diniz BS; Forlenza OV
    Dement Neuropsychol; 2009; 3(3):188-194. PubMed ID: 29213627
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.